GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Marketable Securities

Renalytix (LSE:RENX) Marketable Securities : £0.00 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Renalytix Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Renalytix's Marketable Securities for the quarter that ended in Mar. 2024 was £0.00 Mil.

Renalytix's annual Marketable Securities declined from Jun. 2021 (£6.63 Mil) to Jun. 2022 (£2.23 Mil) and declined from Jun. 2022 (£2.23 Mil) to Jun. 2023 (£1.16 Mil).


Renalytix Marketable Securities Historical Data

The historical data trend for Renalytix's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Marketable Securities Chart

Renalytix Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Marketable Securities
Get a 7-Day Free Trial 0.78 0.79 6.63 2.23 1.16

Renalytix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.16 - 0.96 -

Renalytix Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Renalytix  (LSE:RENX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Renalytix Marketable Securities Related Terms

Thank you for viewing the detailed overview of Renalytix's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Renalytix (LSE:RENX) Business Description

Traded in Other Exchanges
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Investing in Information

By Vanina Egea Vanina Egea 03-06-2014

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe 08-29-2013

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex 12-14-2012